Author/Editor     Čufer, T; Vrdoljak, E
Title     Sign: a Phase II, open-label, randomized study comparing gefitinib (IRESSA) with docetaxel as second-line therapy in patients with advanced (stage IIIb or IV) non-small-cell lung cancer
Type     članek
Source     Lung Cancer
Vol. and No.     Letnik 49, št. Suppl 2
Publication year     2005
Volume     str. S87
Language     eng